<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">X-ray absorption studies of adducts of gold and ruthenium anticancer metallodrugs with serum proteins and fragments of proteins Experiment number: 08-01 802</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Chiara</forename><surname>Maurizio</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">CHIARA MARCHIONI ANTONELLA BALERNA CHIARA GABBIANI</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Isabella</forename><surname>Ascone</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">CHIARA MARCHIONI ANTONELLA BALERNA CHIARA GABBIANI</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">X-ray absorption studies of adducts of gold and ruthenium anticancer metallodrugs with serum proteins and fragments of proteins Experiment number: 08-01 802</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">018CC8D12827AE402A46411DEFEF44F8</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T21:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>11</term>
					<term>03</term>
					<term>09</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The mechanisms through which metal complexes exert their biological and pharmacological effects are still largely unexplored. In particular various gold(III) and gold(I) compounds were shown to be very active in vitro against several human tumor cell lines. However the mechanisms leading to the relevant cytotoxic effects have not been elucidated yet. It seems that the direct interaction of gold compounds with a variety of protein targets may be particularly relevant. This research project was specifically directed to model the interaction of various gold compounds with some typical protiens.</p><p>We performed at GILDA beam line, EXAFS/XANES investigations aimed at characterising, at a molecular level, the adducts that are formed in the reaction of representative metallodrugs (Auxo6, Auranofin, AuL13, Aubipy) with selected proteins: bovine serum albumin (BSA) and Apotransferrin (TF).</p><p>We performed our experiments at Au L 3 -edge 11.92 keV to obtain information on redox state of metals bonded to proteins and to define structural details on metal sites in protein.</p><p>The quality of EXAFS and XANES experimental data was good allowing a reliable simulation of spectra.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Figures 1 show XANES spectra of metallodrugs and of metallodrugs/proteins adducts. In Fig. <ref type="figure">2</ref>, the EXAFS spectra of Auoxo6 metallodrug and Auoxo6 metallodrug/Auoxo6Tf and their fit are shown.</p><p>For Aubipy XANES have been simulated in the frame of non muffin-tin approximation with a good agreement between experimental data and theoretical spectra. The optimized geometries for Au-bipy were calculated by the all-electron density functional theory (DFT) approach implemented 1 in the ADF2008 code. The self-consistent field simulation of Au-bipy is presented in the figure <ref type="figure">3</ref>   In Fig. 2 the EXAFS spectra of Auoxo6 metallodrug and Auoxo6 metallodrug/Auoxo6Tf and their fit are shown Fig.3 Results of the DFT SCF simulations of Au-bipy.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>(Soldatov et al. manuscript in  preparation).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig</head><figDesc>Fig 1 . A Fig. B</figDesc><graphic coords="2,33.96,390.00,257.88,175.08" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
